Inhibiting effects of rosiglitazone on expression of TGF-β1 and FIBRONECTIN in rat hepatocytes cultured with CsA

Basic & Clinical Medicine ›› 2009, Vol. 29 ›› Issue (2): 198-200.

• 研究短文 • Previous Articles Next Articles

Inhibiting effects of rosiglitazone on expression of TGF-β1 and FIBRONECTIN in rat hepatocytes cultured with CsA

Gen-yang CHENG, Jian-sheng LI, Zhang-suo LIU

the First Hospital of Zhengzhou Univercity the First Hospital of Zhengzhou Univercity

Received:2008-02-28 Revised:2008-05-21 Online:2009-02-25 Published:2009-02-25
Contact: Gen-yang CHENG,

Abstract

Gen-yang CHENG; Jian-sheng LI; Zhang-suo LIU. Inhibiting effects of rosiglitazone on expression of TGF-β1 and FIBRONECTIN in rat hepatocytes cultured with CsA[J]. Basic & Clinical Medicine, 2009, 29(2): 198-200.

[1]	CAI Yuan, JIA Changsha, WANG Li, ZHANG Lanfang, YAN Wen. Rosiglitazone inhibits hypertrophic scar formation in rabbit ears [J]. Basic & Clinical Medicine, 2026, 46(11): 1501-1507.
[2]	LIU Xu-zhi, WU Li-gang, ZHANG Shi-yang, ZHAO Wei-ming, WANG Bin, WANG Hao-qing. Clinical observation of COVID-19 treated with fibronectin(FN) inhalation [J]. Basic & Clinical Medicine, 2021, 41(8): 1174-1176.
[3]	WANG Yue, LI Zheng, CHEN Hui, ZHANG Jian-min, HE Wei. Preparation and functional identification of anti-human transforming growth factor β1 nanobodies [J]. Basic & Clinical Medicine, 2020, 40(5): 632-638.
[4]	. The effect of negative pressure wound therapy on TGFβ1 expression in wound granulation tissue from the patients with diabetic foot [J]. Basic & Clinical Medicine, 2017, 37(9): 1323-1325.
[5]	. Role of cyclophilinD in induction of the regulated necrosis [J]. Basic & Clinical Medicine, 2017, 37(11): 1625-1628.
[6]	. Rosiglitazone alleviates vascular endothelial dysfunction in type 2 diabetic rats [J]. Basic & Clinical Medicine, 2017, 37(11): 1585-1589.
[7]	Yu GAO; Hui-juan MA; Jing WANG; Dong-ming QU; Guang-yao SONG; Shu-guo HU. Rosiglitazone up-regulates expression of CPTⅠand PPARγ in skeletal muscles of aged rat fed high-fat diets [J]. Basic & Clinical Medicine, 2010, 30(9): 935-939.
[8]	Hua-bo LI. Pravastatin and rosiglitazone combination therapy increase the expression of ABCA1 in monocytes of coronary heart disease [J]. Basic & Clinical Medicine, 2010, 30(10): 1096-1097.
[9]	Quan HE; Han LEI; Qing LIU; Shu QIN; Kang-hua MA; Xi WANG. Effect of rosiglitazone on no-reflow after reperfusion in rats with AMI [J]. Basic & Clinical Medicine, 2009, 29(8): 816-820.
[10]	Liang-hong WU; Nan-sheng CHENG; Fan YANG; Xian-ze XIONG; Da-peng WEI; Qing-jie XIA. The effect of PPAR-γ ligand RGZ on expression in transplantation tumor of Cholangiocarcinoma [J]. Basic & Clinical Medicine, 2008, 28(2): 128-132.

Inhibiting effects of rosiglitazone on expression of TGF-β1 and FIBRONECTIN in rat hepatocytes cultured with CsA

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

Comments